MiRNA 툴 및 서비스 시장 규모, 점유율, 성장 분석, 제품 유형별, 기술별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Global MiRNA Tools Services Market size was valued at USD 372.1 million in 2023 and is poised to grow from USD 418.98 million in 2024 to USD 1082.69 million by 2032, growing at a CAGR of 12.6% during the forecast period (2025-2032).

The global miRNA tools and services market is experiencing robust growth driven by the increasing incidence of chronic and genetic diseases, alongside heightened investments in research and development from pharmaceutical and biotech sectors. Favorable government policies and technological advancements in molecular biology enhance the precision and affordability of these tools and services. The proliferation of contract research organizations presents opportunities to optimize costs and navigate technical hurdles. Collaborative initiatives and data sharing in life sciences enhance the accessibility of these tools. Additionally, awareness of miRNA's significance in agriculture and veterinary sciences broadens its application. Furthermore, the integration of AI, machine learning, IoT, augmented reality, and virtual reality is revolutionizing the market by improving data analysis, regulatory compliance, and educational training.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MiRNA Tools Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MiRNA Tools Services Market Segments Analysis

Global MiRNA Tools Services Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into miRNA Expression Analysis, miRNA Isolation and Purification, miRNA Sequencing, miRNA Inhibitors and miRNA Mimics. Based on Technology, the market is segmented into Microarray, Quantitative PCR, Next-Generation Sequencing and Northern Blotting. Based on Application, the market is segmented into Research, Diagnostics, Therapeutics and Agriculture. Based on End User, the market is segmented into Academic and Research Institutions, Biotechnology Companies, Pharmaceutical Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MiRNA Tools Services Market

One key market driver for the Global miRNA Tools Services Market is the increasing prevalence of chronic diseases, which has spurred research and development in personalized medicine. As miRNAs are recognized for their critical roles in gene expression and regulation, their profiling and analysis have become essential for understanding disease mechanisms and developing targeted therapies. The growing demand for advanced diagnostic tools and therapeutic solutions is prompting investments in miRNA research, which further drives innovation and expansion in miRNA tools and services. Consequently, this trend enhances the market's potential by fostering collaborations between academic institutions, biotechnology firms, and pharmaceutical companies.

Restraints in the Global MiRNA Tools Services Market

One key market restraint for the global miRNA tools services market is the high cost associated with advanced sequencing technologies and specialized equipment required for miRNA analysis. These costs can be a barrier for small and medium-sized laboratories and research institutions, limiting their ability to invest in sophisticated miRNA tools and services. Additionally, the complexity of data interpretation and the need for skilled personnel to analyze and validate results further complicate market access for some stakeholders. This financial burden may hinder innovation and wider adoption of miRNA technologies, ultimately slowing down market growth and development.

Market Trends of the Global MiRNA Tools Services Market

The Global miRNA Tools Services market is experiencing a notable trend toward increased adoption in diagnostic applications, particularly for cardiovascular diseases, neurological disorders, and infectious diseases. The shift toward non-invasive diagnostic methods is driving demand for the precise and accurate capabilities of miRNA tools and services. Alongside this, enhanced government initiatives aimed at bolstering healthcare infrastructure-coupled with grants and incentives for miRNA research-are catalyzing a broader acceptance and integration of these services in clinical settings. This convergence of technological innovation, healthcare demand, and supportive policies positions the miRNA tools market for sustained growth and expansion in the diagnostics landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global MiRNA Tools Services Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• miRNA Expression Analysis
• miRNA Isolation and Purification
• miRNA Sequencing
• miRNA Inhibitors
• miRNA Mimics

Global MiRNA Tools Services Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Microarray
• Quantitative PCR
• Next-Generation Sequencing
• Northern Blotting

Global MiRNA Tools Services Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research
• Diagnostics
• Therapeutics
• Agriculture

Global MiRNA Tools Services Market Size by End User & CAGR (2025-2032)

• Market Overview
• Academic and Research Institutions
• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organizations

Global MiRNA Tools Services Market Size & CAGR (2025-2032)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc. (NEB) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (IDT) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• System Biosciences (SBI) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations